These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23715831)

  • 1. Prognostic implications of post-therapy (18)F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Chan SC; Kuo WH; Wang HM; Chang JT; Lin CY; Ng SH; Hsu CL; Chang KP; Liao CT; Lin YJ; Yen TC
    Ann Nucl Med; 2013 Oct; 27(8):710-9. PubMed ID: 23715831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
    Chan SC; Chang JT; Lin CY; Ng SH; Wang HM; Liao CT; Chang CJ; Lin SY; Yen TC
    Nucl Med Commun; 2011 Nov; 32(11):989-96. PubMed ID: 21862944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
    Liu FY; Lin CY; Chang JT; Ng SH; Chin SC; Wang HM; Liao CT; Chan SC; Yen TC
    J Nucl Med; 2007 Oct; 48(10):1614-9. PubMed ID: 17873135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
    Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
    Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck MRI-based T stage and [
    Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
    Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.
    Chan SC; Chang JT; Wang HM; Lin CY; Ng SH; Fan KH; Chin SC; Liao CT; Yen TC
    Oral Oncol; 2009 Jan; 45(1):52-8. PubMed ID: 18487079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yen RF; Chen TH; Ting LL; Tzen KY; Pan MH; Hong RL
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1152-9. PubMed ID: 15965687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liu WS; Wu MF; Tseng HC; Liu JT; Weng JH; Li YC; Lee JK
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):561-6. PubMed ID: 21300483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma.
    Ma BB; Mo FK; Chan AT; Hui EP; Leung SF; Lo YM; Yau YY; King AD
    Oral Oncol; 2008 Nov; 44(11):1067-72. PubMed ID: 18396444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of early evaluation of treatment response using
    Chen YH; Chang KP; Chu SC; Yen TC; Wang LY; Chang JT; Hsu CL; Ng SH; Liu SH; Chan SC
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):650-660. PubMed ID: 30264225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
    Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
    Yen RF; Hong RL; Tzen KY; Pan MH; Chen TH
    J Nucl Med; 2005 May; 46(5):770-4. PubMed ID: 15872349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.
    Huang B; Chan T; Kwong DL; Chan WK; Khong PL
    AJR Am J Roentgenol; 2012 Jul; 199(1):169-74. PubMed ID: 22733909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.